News search

    E.g., 06/07/2026
    E.g., 06/07/2026
    Alzheimer's_Dementia
    About the CNIC
    6 Jul 2026
    Alzheimer's & Dementia: A new imaging technique locates microthrombi that worsen Alzheimer’s disease, opening the way to personalized anticoagulant therapy

    This tool paves the way for identifying patients who would be suitable candidates for treatment with anticoagulant therapy already available at the clinic 
    Dilated coronary artery in a new experimental model of Kawasaki disease.
    Research
    1 Jul 2026
    Circulation: Researchers Identify a Key Mechanism Driving Coronary Damage in Kawasaki Disease

    The findings provide new insights for developing strategies aimed at preventing the cardiovascular complications associated with this rare disease
    Maria Ruiz Castell
    Research
    29 Jun 2026
    Marina Ruiz Castell: "There is often a tendency to design top-down solutions without fully considering people’s real needs"
    Rocío Sierra, Miguel Torres, Cristina Villa del Campo, Enrique Calvo, Jesús Vázquez y Consuelo Marín-Vicente.
    Research
    24 Jun 2026
    Genome Biology: A new technology helps reveal how the heart generates cells with regenerative potential

    Two CNIC teams have developed a pioneering technique to analyze proteins in individual cardiomyocytes and uncover new clues about cardiac regeneration
    Florian Weinberg
    About the CNIC
    23 Jun 2026
    CNIC Researcher Florian Weinberger Awarded ERC Advanced Grant for the project CARDIOSWITCH

    CARDIOSWITCH aims to uncover how the mechanical activity of heart muscle cells shapes cardiac biology and to develop new regenerative strategies for congenital heart disease
    About the CNIC
    11 Jun 2026
    CNIC and Fundación AstraZeneca bring together young scientists and European leaders in Madrid to advance the “SAFE HEARTS PLAN”

    The meeting forms part of European awareness-raising activities around the European Commission’s new strategy to strengthen prevention, early detection, and management of cardiovascular disease
    Optimal dendritic-cell-based antitumor immunotherapy with cDC1 cells requires active mitochondria. Whereas vaccination with normal cDC1 cells efficiently reduces metastasis in B16-OVA tumors, the antitumor efficacy of these cells is diminished when their mitochondria are damaged.
    Research
    22 May 2026
    Science Immunology: Mitochondria control immune cell activation and the effectiveness of immunotherapy

    A CNIC-led study identifies a mitochondrial “checkpoint” that enables dendritic cells to efficiently activate T lymphocytes against viruses and tumors
    Francesco Costa
    Research
    18 May 2026
    Dr. Francesco Costa: "The sustained use of tools like ChatGPT produces a phenomenon called deskilling"
    Faseeha Ayaz
    Research
    30 Apr 2026
    Faseeha Ayaz: "I would say the editors are very much on the researchers’ side"

    Faseeha Ayaz, senior Editor Nature Communications, Springer Nature
    Dr. Pablo García-Pavía junto con la Dra. Noelia Mora y la Dra. Belén Peiró
    Research
    21 Apr 2026
    CNIC scientists identify a biomarker that improves risk prediction in a severe form of heart failure

    The biomarker MR-proADM improves risk prediction in patients with transthyretin amyloid cardiomyopathy (ATTR-CM) and is associated with greater disease severity, mortality, and heart failure events.